End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.28 CNY | -5.39% | -11.14% | +21.46% |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 61.4 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+21.46% | 715M | - | ||
+7.26% | 4B | D+ | ||
+14.41% | 1.89B | B+ | ||
+27.04% | 1.11B | - | ||
+4.75% | 1.01B | D+ | ||
+51.77% | 738M | - | - | |
+51.00% | 690M | B- | ||
-3.74% | 671M | - | - | |
+24.69% | 546M | - | D+ | |
-20.59% | 441M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300758 Stock
- Ratings Anshan Hifichem Co., Ltd.